Price $110.43 |
Market Cap
988.7M
|
Sector Health Care |
Div. Growth
-8.00%
|
|
P/E
33.0
|
P/B
3.99
|
P/S
2.34
|
Dividend %
1.60%
|
|
P/CF
114.8
|
P/FCF
15.7
|
Op. Cash Flow
82.2K
|
FCF
5.0
|
|
Op. Margin
12.50%
|
Net Margin
7.10%
|
ROE
12.60%
|
ROI
18.50%
|
|
ROA
5.20%
|
EPS Growth
32.80%
|
Current Ratio
1.4
|
Debt/Equity
21.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.55 | - | - | 17.9M | Strong Buy |
| NuVasive, Inc. (NUVA) | $48.03 | - | - | 2.53B | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $2.97 | - | - | 45.6M | Strong Buy |
| Micron Solutions Inc (MICR) | $2.73 | - | - | 6.1M | Strong Buy |
| Elite Pharmaceuticals Inc (ELTP) | $0.05 | - | - | 53.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
